Delix Therapeutics

Delix Therapeutics, Inc. is a new company focused on drug discovery for the central nervous system. Its compounds are small molecules that are easy to manufacture and can rapidly induce structural and functional neural changes in targeted brain regions. Many of these molecules are inspired by psychedelic compounds, retaining their efficacy-promoting mechanisms while avoiding their hallucinogenic properties and other safety liabilities. Delix is rapidly advancing these compounds through preclinical and clinical development to bring FDA-approved, take-home medications to patients, addressing several unmet needs.